Daiichi Sankyo and AstraZeneca’s Enhertu Plus Pertuzumab Approved in China for First-Line HER2+ Metastatic Breast Cancer
FDA is Announcing an Upcoming Meeting
Financial Toxicity in Cancer Care: A Global Call for Submissions
Julie Gralow on Why Federal Funding Matters for the Future of Cancer Research
Alejandra Mendez Highlights the Impact of the Zero Abandonment Programme in Childhood Cancer
ctDNA in Early Breast Cancer: Powerful Promise, Key Gaps
Shane Jacobson: New $5.45 Million Fund to Empower the Next Generation of Cancer Scientists
Medical Oncology vs Radiation Oncology: Who Does What in Cancer Care?
